UNSPSC 51293201: Iproniazid or iproniazide
Commodity
Code facts
- Part of
-
-
51000000
-
51290000
- 51293200
-
51290000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51293201
Definition
This classification denotes an antidepressive agent and monoamine oxidase inhibitor with the molecular formula C9H13N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D892HFI3XA, chemically known as 4-pyridinecarboxylic acid, 2-(1-methylethyl)hydrazide but generally known as iproniazid, which bears US NIH Compound Identifier 3748. European Medicines Agency schedules Iproniazid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08283MIG.
Read the full definition
IPRONIAZID is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule iproniazid under HS 29333910 and SITC 51574. As of Q4 2014, IPRONIAZID remains the US FDA Preferred Term for this commodity. Iproniazid bears US NLM identifiers UMLS ID C0022059 and NCI Concept Code C97714. SMILES: O=C(NNC(C)C)c1ccncc1.
About UNSPSC 51293201
UNSPSC 51293201 Iproniazid or iproniazide is a Commodity code that shows limited alignment between its nominal pharmaceutical scope and recent state and local procurement activity. The single recent opportunity in the dataset — Seminole County, Florida's IFB for naloxone and drug deactivation systems — involves emergency response and public health products that fall outside the specific drug category named in the code. State and local governments buying under this code appear to be sourcing pharmaceutical products for health and safety initiatives, though the available record does not demonstrate sustained or widespread activity. The issuing bodies are county-level health and public safety agencies pursuing fixed-fee procurement through competitive bidding, with standard requirements for E-Verify compliance, drug-free workplace certification, and insurance coverage.
Geographic activity is concentrated in Florida, with Seminole County's procurement representing the recent opportunity in the dataset. Seminole County's IFB60459723LAS, posted June 30, 2026, solicited 1,900 units of naloxone and 800 safe drug deactivation systems annually through a competitive bidding process with a response deadline of July 26, 2023, at 2:00 pm. Quarterly deliveries were required to the Seminole County Community Health Building in Sanford, Florida, with all shipping and delivery costs included in vendor pricing. The contract included a two-year initial term with a one-year renewal option and a three-month probationary period permitting termination with or without cause. The procurement carried potential FEMA funding and associated federal compliance obligations. Beyond this single solicitation, the code shows no recent state and local procurement activity in the available records.
Quick answers
What is UNSPSC 51293201?
UNSPSC 51293201 is Iproniazid or iproniazide, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51293201?
UNSPSC 51293201 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51293201
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code